Squarepoint Ops LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$17.63 - $21.74 $163,377 - $201,464	-9,267 Reduced 40.7%	13,501 $266,000
Q4 2023 Feb 14, 2024	SELL	$14.37 - $19.07 $398,135 - $528,353	-27,706 Reduced 54.89%	22,768 $399,000
Q2 2023 Aug 14, 2023	BUY	$10.44 - $16.48 $322,898 - $509,709	30,929 Added 158.25%	50,474 $710,000
Q1 2023 May 15, 2023	BUY	$10.7 - $15.79 $78,987 - $116,561	7,382 Added 60.69%	19,545 $210,000
Q4 2022 Feb 14, 2023	BUY	$11.42 - $17.05 $138,901 - $207,379	12,163 New	12,163 $182,000
Q3 2021 Nov 15, 2021	SELL	$11.39 - $16.23 $327,394 - $466,515	-28,744 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$13.22 - $19.09 $379,995 - $548,722	28,744 New	28,744 $400,000
Q1 2021 May 17, 2021	SELL	$16.68 - $23.97 $885,291 - $1.27 Million	-53,075 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$14.8 - $21.15 $229,163 - $327,486	15,484 Added 41.19%	53,075 $938,000
Q3 2020 Nov 16, 2020	BUY	$15.21 - $25.53 $221,442 - $371,691	14,559 Added 63.21%	37,591 $576,000
Q2 2020 Aug 14, 2020	BUY	$15.08 - $26.0 $190,505 - $328,458	12,633 Added 121.48%	23,032 $587,000
Q1 2020 May 15, 2020	SELL	$11.0 - $19.76 $1.21 Million - $2.18 Million	-110,423 Reduced 91.39%	10,399 $161,000
Q4 2019 Feb 14, 2020	BUY	$5.24 - $12.96 $481,692 - $1.19 Million	91,926 Added 318.13%	120,822 $1.34 Million
Q3 2019 Nov 14, 2019	SELL	$8.15 - $15.88 $77,457 - $150,923	-9,504 Reduced 24.75%	28,896 $246,000
Q2 2019 Aug 14, 2019	BUY	$13.2 - $20.39 $156,552 - $241,825	11,860 Added 44.69%	38,400 $520,000
Q1 2019 May 15, 2019	BUY	$15.93 - $26.59 $187,782 - $313,442	11,788 Added 79.91%	26,540 $479,000
Q4 2018 Feb 14, 2019	BUY	$16.25 - $28.09 $36,123 - $62,444	2,223 Added 17.74%	14,752 $414,000
Q3 2018 Nov 14, 2018	BUY	$13.23 - $30.93 $165,758 - $387,521	12,529 New	12,529 $319,000

Others Institutions Holding KNSA

# of Institutions

Shares Held

1.95M

Call Options Held

Put Options Held

Pictet Asset Management Sa Geneva 73, V8

1.52M
Shares

$33.1 Million
0.03% of portfolio
Spearhead Capital Advisors, LLC Wellington, FL

203K
Shares

$4.42 Million
2.82% of portfolio
Harbor Capital Advisors, Inc.

97.5K
Shares

$2.13 Million
0.11% of portfolio
Putnam Investments LLC Boston, MA

39.5K
Shares

$860,794
0.0% of portfolio
Birchview Capital, LP Burlington, VT

30K
Shares

$654,000
0.69% of portfolio

View Full List

About Kiniksa Pharmaceuticals, Ltd.

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $751M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

More about KNSA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account